3 Growth Companies With High Insider Ownership Expecting 68% Revenue Growth
Hennessy Capital Investment Corp. VII Class A HVII | 0.00 |
In the last week, the United States market has stayed flat, but it has seen a 20% increase over the past year with earnings expected to grow by 18% annually. In this context of steady growth, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Uxin (UXIN) | 34.3% | 69.4% |
| Upstart Holdings (UPST) | 14.1% | 60% |
| Laird Superfood (LSF) | 16.7% | 115.9% |
| Karman Holdings (KRMN) | 15.6% | 52.6% |
| IREN (IREN) | 13.6% | 38.8% |
| ERock (EROC) | 20.1% | 56.3% |
| Corcept Therapeutics (CORT) | 10.9% | 48.9% |
| Cerebras Systems (CBRS) | 10.9% | 73.7% |
| AppLovin (APP) | 23.2% | 21.7% |
| Abeona Therapeutics (ABEO) | 16.2% | 32.9% |
Let's uncover some gems from our specialized screener.
Evolus (EOLS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Evolus, Inc. is a performance beauty company that provides products in the cash-pay aesthetic market across the United States, Canada, Europe, and Australia with a market cap of $429.37 million.
Operations: The company's revenue segment focuses on delivering medical aesthetic products to the cash-pay market, generating $301.79 million.
Insider Ownership: 11.1%
Revenue Growth Forecast: 14.4% p.a.
Evolus has been expanding its injectable portfolio with an exclusive licensing agreement to commercialize Profhilo in the U.S., enhancing its presence in the growing skin quality segment. Despite negative shareholder equity, Evolus is trading significantly below estimated fair value and expects revenue growth of 14.4% annually, outpacing the broader U.S. market. The company anticipates becoming profitable within three years, aligning with above-average market growth expectations, without recent insider trading activity noted.
Hennessy Capital Investment VII (HVII)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Hennessy Capital Investment Corp. VII is a company without significant operations and has a market cap of $272.43 million.
Operations: Hennessy Capital Investment Corp. VII currently does not generate revenue from distinct segments.
Insider Ownership: 25.5%
Revenue Growth Forecast: 68.2% p.a.
Hennessy Capital Investment VII is positioned for substantial growth, with anticipated revenue and earnings expansion of 68.2% and 74.8% annually, respectively, outpacing the US market averages. Despite generating less than US$1 million in revenue currently, its earnings surged by over 300% last year. Recent financial results showed a decline in net income to US$0.58 million from US$1.02 million year-over-year, yet no significant insider trading activity has been reported recently.
Upstart Holdings (UPST)
Simply Wall St Growth Rating: ★★★★★★
Overview: Upstart Holdings, Inc. operates a cloud-based AI lending platform in the United States and has a market cap of approximately $3.01 billion.
Operations: The company's revenue primarily comes from its personal lending segment, which generated $1.01 billion.
Insider Ownership: 14.1%
Revenue Growth Forecast: 21.6% p.a.
Upstart Holdings demonstrates significant growth potential, with revenue projected to increase by 21.6% annually, surpassing the US market average. Insider ownership is strong, evidenced by substantial insider buying over the past three months without notable selling. Despite a recent net loss of US$6.65 million for Q1 2026, earnings are forecast to grow at an impressive 60% per year. The company has secured partnerships with multiple credit unions to expand its AI-driven lending platform's reach nationwide.
Seize The Opportunity
- Dive into all 168 of the Fast Growing US Companies With High Insider Ownership we have identified here.
- Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 129 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
